JASON PHILIPPE: Open Payments
NPI 1982165775 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 23 payments from 8 companies in 2025. Trend: 2023 $746 · 2024 $902 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $101 |
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| Novo Nordisk Inc | 3 | $68 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Lilly USA, LLC | 3 | $63 |
| Amgen Inc. | 2 | $33 |
| Exact Sciences Corporation | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: Ozempic, TRELEGY ELLIPTA, UBRELVY, FARXIGA, AIRSUPRA, QULIPTA, OTEZLA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
